

info@averywell.com

  • Follow
  • Home
  • Our Mission
  • Our Technology
  • Contact Us
  • News & Blogs

Invitrocue and Angsana Partner with Averywell to Advance Early Lung Cancer Detection Across Asia

by admin | Apr 17, 2026 | News&blogs, Uncategorized

SINGAPORE — Invitrocue and Angsana Molecular & Diagnostics Laboratory have announced a strategic partnership with Averywell to introduce a next-generation, miRNA-based liquid biopsy for early lung cancer detection. The collaboration integrates advanced molecular...

Averywell revolutionizes late-stage lung cancer diagnosis in the UK with a groundbreaking miRNA-based liquid biopsy. Our non-invasive, precise, and cost-effective technology ensures early detection, enabling timely treatment access for smokers and non-smokers.

Contact Information

Email: info@averywell.com

  • Follow
© 2026 Averywell | All Rights Reserved.